Cargando…

Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis

BACKGROUND: Psoriasis localized to certain body areas, such as the scalp, nails, palms, soles, intertriginous regions, and genital regions, is reportedly difficult to treat. OBJECTIVE: To investigate the biologics-resistant areas in South Korean patients with psoriasis treated with biologics. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Won, Sang-Hyeon, Shin, Bong Seok, Bae, Kyung-Nam, Son, Jin-Hwa, Shin, Kihyuk, Kim, Hoon-Soo, Ko, Hyun-Chang, Kim, Moon-Bum, Kim, Byung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905854/ https://www.ncbi.nlm.nih.gov/pubmed/36750453 http://dx.doi.org/10.5021/ad.21.274

Ejemplares similares

Change in the Usage of Complementary and Alternative Medicine in the Era of Biologics Among Korean Patients With Psoriasis
por: Kim, Yeona, et al.
Publicado: (2023)

Unilateral Psoriasis on the Left Leg and Poliomyelitis of the Right Leg: A Case Report and Review of the Etiology
por: Kim, Jongwook, et al.
Publicado: (2023)

Dominant Dystrophic Epidermolysis Bullosa with a Mutation in COL7A1 Confirmed by Diagnostic Exome Sequencing
por: Won, Sang-Hyeon, et al.
Publicado: (2022)

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate
por: Bae, Kyung-Nam, et al.
Publicado: (2021)

Giant Cellulitis-like Sweet Syndrome Following Varicose Vein Surgery: A Rare Variant of Sweet Syndrome Mimicking Cellulitis
por: Bae, Kyung-Nam, et al.
Publicado: (2023)

Halo Scalp Ring: An Annular Alopecia Associated with Birth Injury
por: Shin, Jun-Oh, et al.
Publicado: (2023)

Scar Sarcoidosis: A Retrospective Investigation into Its Peculiar Clinicopathologic Presentation
por: Bae, Kyung-Nam, et al.
Publicado: (2022)

Analysis of Cardiovascular Risk Factors and Metabolic Syndrome in Korean Patients with Psoriasis
por: Kim, Gun-Wook, et al.
Publicado: (2012)

Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Bullous Wells Syndrome Induced by Ustekinumab
por: Kim, Yeona, et al.
Publicado: (2023)

Venous Insufficiency is a Clear Provoker of Pigmented Purpuric Dermatosis
por: Kim, Hak-Jun, et al.
Publicado: (2022)

Percutaneous Bleomycin Sclerotherapy: A Useful Therapeutic Option for Ganglion Cysts
por: Shin, Kihyuk, et al.
Publicado: (2023)

Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study
por: Seo, Seong Jun, et al.
Publicado: (2020)

Cryosurgery as a Minimally Invasive Alternative Treatment for a Patient with Erosive Adenomatosis of the Nipple
por: Bae, Kyung-Nam, et al.
Publicado: (2021)

Deeply Located Infantile Hemangioma with Rapid Growth Resembles Malignancy
por: Ha, Dae-Lyong, et al.
Publicado: (2021)

Cutaneous Aspergillosis As a First Manifestation of Systemic Infection in Patient After Kidney Transplantation
por: Park, Geun-Hwi, et al.
Publicado: (2022)

Pleomorphic Adenoma Arising from Post-Auricular Heterotopic Salivary Gland Tissue
por: Kim, Yeona, et al.
Publicado: (2023)

Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire
por: You, Hyang-Suk, et al.
Publicado: (2015)

Pigmented Fungiform Papillae of the Tongue: A Single-center Experience and Review of Literature
por: Lee, Jungsoo, et al.
Publicado: (2023)

Tissue and Serum Inflammatory Cytokine Levels in Korean Psoriasis Patients: A Comparison between Plaque and Guttate Psoriasis
por: Roh, Nam Kyung, et al.
Publicado: (2015)

Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center
por: Kwon, Soo Hyun, et al.
Publicado: (2020)

A Novel Mutation in the MBTPS2 Gene Resulting in Ichthyosis Follicularis, Atrichia, and Photophobia Syndrome
por: Shin, Jun-Oh, et al.
Publicado: (2022)

Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31
por: Park, Sung-Min, et al.
Publicado: (2020)

Dermoscopic “Landscape Painting Patterns” as a Clue for Labial Melanotic Macules: An Analysis of 80 Cases
por: Kim, Gun-Wook, et al.
Publicado: (2018)

Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016)

Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Erratum: Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus
por: Park, Sung-Min, et al.
Publicado: (2018)

Association Between FcgammaR IIa and IIIa polymorphism and clinical manifestations in Korean patients with adult-onset Still's disease.
por: Oh, Young Bae, et al.
Publicado: (2002)

Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C
por: Kim, Gun-Wook, et al.
Publicado: (2013)

Two Cases of Generalized Pustular Psoriasis: Successful Treatment with Infliximab
por: Kim, Hoon-Soo, et al.
Publicado: (2014)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Moderate and severe plaque psoriasis: cost-of-illness study in Italy
por: Colombo, GL, et al.
Publicado: (2008)

The experience of pain and redness in patients with moderate to severe plaque psoriasis
por: Martin, Mona L., et al.
Publicado: (2015)

Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Ren, Vicky, et al.
Publicado: (2013)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon, Sahil, et al.
Publicado: (2017)

Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Population pharmacokinetics of brodalumab in patients with moderate to severe plaque psoriasis
por: Timmermann, Stine, et al.
Publicado: (2019)

Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil
por: Lopes, Nilcéia, et al.
Publicado: (2019)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
por: Light, Jeremy G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_re4mit01klvpd2nic94micfgot